Sensei Biotherapeutics (SNSE) Competitors $0.46 +0.07 (+19.27%) Closing price 04:00 PM EasternExtended Trading$0.42 -0.03 (-7.21%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNSE vs. LVTX, AKTX, ALLK, ALXO, HOWL, BRNS, TPST, CVKD, FGEN, and IRDShould you be buying Sensei Biotherapeutics stock or one of its competitors? The main competitors of Sensei Biotherapeutics include LAVA Therapeutics (LVTX), Akari Therapeutics (AKTX), Allakos (ALLK), ALX Oncology (ALXO), Werewolf Therapeutics (HOWL), Barinthus Biotherapeutics (BRNS), Tempest Therapeutics (TPST), Cadrenal Therapeutics (CVKD), FibroGen (FGEN), and Opus Genetics (IRD). These companies are all part of the "pharmaceutical products" industry. Sensei Biotherapeutics vs. LAVA Therapeutics Akari Therapeutics Allakos ALX Oncology Werewolf Therapeutics Barinthus Biotherapeutics Tempest Therapeutics Cadrenal Therapeutics FibroGen Opus Genetics Sensei Biotherapeutics (NASDAQ:SNSE) and LAVA Therapeutics (NASDAQ:LVTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings, community ranking and institutional ownership. Do institutionals and insiders believe in SNSE or LVTX? 10.5% of Sensei Biotherapeutics shares are owned by institutional investors. 22.0% of Sensei Biotherapeutics shares are owned by insiders. Comparatively, 0.8% of LAVA Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts prefer SNSE or LVTX? Sensei Biotherapeutics currently has a consensus target price of $4.25, suggesting a potential upside of 827.95%. LAVA Therapeutics has a consensus target price of $3.17, suggesting a potential upside of 177.78%. Given Sensei Biotherapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Sensei Biotherapeutics is more favorable than LAVA Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00LAVA Therapeutics 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is SNSE or LVTX more profitable? Sensei Biotherapeutics' return on equity of -53.86% beat LAVA Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sensei BiotherapeuticsN/A -53.86% -46.91% LAVA Therapeutics N/A -62.22%-29.37% Does the media refer more to SNSE or LVTX? In the previous week, Sensei Biotherapeutics and Sensei Biotherapeutics both had 2 articles in the media. LAVA Therapeutics' average media sentiment score of 1.43 beat Sensei Biotherapeutics' score of 0.44 indicating that LAVA Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Sensei Biotherapeutics Neutral LAVA Therapeutics Positive Which has more volatility and risk, SNSE or LVTX? Sensei Biotherapeutics has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, LAVA Therapeutics has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Does the MarketBeat Community believe in SNSE or LVTX? Sensei Biotherapeutics received 5 more outperform votes than LAVA Therapeutics when rated by MarketBeat users. Likewise, 81.08% of users gave Sensei Biotherapeutics an outperform vote while only 65.79% of users gave LAVA Therapeutics an outperform vote. CompanyUnderperformOutperformSensei BiotherapeuticsOutperform Votes3081.08% Underperform Votes718.92%LAVA TherapeuticsOutperform Votes2565.79% Underperform Votes1334.21% Which has stronger valuation and earnings, SNSE or LVTX? Sensei Biotherapeutics has higher earnings, but lower revenue than LAVA Therapeutics. LAVA Therapeutics is trading at a lower price-to-earnings ratio than Sensei Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensei BiotherapeuticsN/AN/A-$34.10M-$1.20-0.38LAVA Therapeutics$11.98M2.50-$41.97M-$0.93-1.23 SummarySensei Biotherapeutics beats LAVA Therapeutics on 10 of the 15 factors compared between the two stocks. Remove Ads Get Sensei Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SNSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNSE vs. The Competition Export to ExcelMetricSensei BiotherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.55M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.32%P/E Ratio-0.386.7921.7317.81Price / SalesN/A225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book0.185.866.464.00Net Income-$34.10M$141.86M$3.20B$247.23M7 Day Performance53.38%8.98%6.54%7.26%1 Month Performance1.55%-12.65%-8.55%-6.26%1 Year Performance-54.43%-11.99%10.33%-0.18% Sensei Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSESensei Biotherapeutics4.1169 of 5 stars$0.46+19.3%$4.25+827.9%-63.4%$11.55MN/A-0.3840Short Interest ↑LVTXLAVA Therapeutics2.4479 of 5 stars$1.14-1.7%$3.17+177.8%-62.9%$29.99M$11.98M-1.1160Short Interest ↓Gap DownAKTXAkari TherapeuticsN/A$1.10-1.4%N/A-8.0%$29.66MN/A0.009Positive NewsGap UpALLKAllakos4.4785 of 5 stars$0.32+1.4%$2.00+526.0%-71.1%$28.82MN/A-0.16190Positive NewsALXOALX Oncology3.3417 of 5 stars$0.54+3.8%$4.14+673.4%-96.2%$28.58MN/A-0.1840Gap UpHOWLWerewolf Therapeutics2.4939 of 5 stars$0.63-9.8%$9.00+1,328.6%-83.5%$28.24M$1.89M-0.4140Gap UpBRNSBarinthus Biotherapeutics3.0139 of 5 stars$0.69+1.8%$5.17+644.5%-77.7%$28.00M$14.97M-0.47107Short Interest ↓Positive NewsTPSTTempest Therapeutics2.2857 of 5 stars$0.51-17.6%$9.33+1,745.3%-85.1%$27.93MN/A-0.3320Short Interest ↓CVKDCadrenal Therapeutics2.6821 of 5 stars$14.68-9.2%$32.00+118.0%N/A$27.60MN/A-2.204Gap DownFGENFibroGen4.4853 of 5 stars$0.27-2.5%$10.00+3,561.7%-76.9%$27.56M$29.62M-0.22570Analyst ForecastPositive NewsIRDOpus Genetics1.9632 of 5 stars$0.85-4.5%$8.00+845.6%N/A$27.11M$10.99M-0.7814Gap Up Remove Ads Related Companies and Tools Related Companies LVTX Alternatives AKTX Alternatives ALLK Alternatives ALXO Alternatives HOWL Alternatives BRNS Alternatives TPST Alternatives CVKD Alternatives FGEN Alternatives IRD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNSE) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNSE Stock Free SNSE Stock Alerts